CD4 and diabetes mellitus: Ten days post-implantation, a time at which recurrent diabetes is first detected, TCR Vβ usage by CD4+ and CD8+ naïve and Teff/mem was examined in the islet graft, the renal lymph node (RLN) draining the graft site, pancreas, pancreatic lymph node (PLN), and spleen of individual recipients.